Gould Robert J
SEC CIK 1577034 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | Dir | 454.9K | — | $4.29M | 13 | 2022-04-01 | 2026-02-02 |
Most active insiders at FULC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA Capital Healthcare Fund LP | 10% | — | $58.38M |
| 2 | TANG KEVIN | 10% | $1.49M | — |
| 3 | Gould Robert J | Dir | — | $667.4K |
| 4 | Ezekowitz Alan | Dir | — | $65.6K |
| 5 | Oltmans Curtis Gale | CLO | — | $44.6K |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-02-04 | 2026-01-02 | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | S - Sale | $10.87 | -15.0K | 469.9K | -3% | -$163.1K |
| 2026-02-04 | 2026-02-02 | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | S - Sale | $10.72 | -15.0K | 454.9K | -3% | -$160.8K | |
| 2026-01-06 | 2026-01-02 | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | S - Sale | $11.87 | -15.0K | 469.9K | -3% | -$178.1K | |
| 2025-11-21 | 2025-11-19 | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | S - Sale | $11.03 | -15.0K | 484.9K | -3% | -$165.4K | |
| 2023-01-13 | 2023-01-13 | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | CEO, Interim Pres, Dir | S - Sale | $15.00 | -6,766 | 499.9K | -1% | -$101.5K | |
| D | 2022-06-08 | 2022-06-07 | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | S - Sale+OE | $8.09 | -71.4K | 506.6K | -12% | -$577.9K |
| D | 2022-06-08 | 2022-06-07 | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | M - OptEx | $7.84 | +71.4K | 578.1K | +14% | +$560.1K |
| DM | 2022-06-06 | 2022-06-02+ | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | S - Sale+OE | $8.00 | -66.6K | 506.6K | -12% | -$532.8K |
| DM | 2022-06-06 | 2022-06-02+ | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | M - OptEx | $7.84 | +66.6K | 532.2K | +14% | +$522.3K |
| D | 2022-04-11 | 2022-04-07 | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | S - Sale+OE | $24.02 | -5,631 | 506.6K | -1% | -$135.3K |
| D | 2022-04-11 | 2022-04-07 | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | M - OptEx | $7.84 | +5,631 | 512.3K | +1% | +$44.1K |
| DM | 2022-04-05 | 2022-04-01+ | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | M - OptEx | $7.84 | +94.3K | 559.2K | +20% | +$738.9K |
| DM | 2022-04-05 | 2022-04-01+ | FULC | Fulcrum Therapeutics, Inc. | Gould Robert J | Dir | S - Sale+OE | $24.16 | -94.3K | 506.6K | -16% | -$2.28M |
Purchase Sale Sale after option exercise All abbreviations